Home > News > BioSante Pharmaceuticals Presents New Anthrax Vaccine Data
March 22nd, 2006
BioSante Pharmaceuticals Presents New Anthrax Vaccine Data
Abstract:
Dr. Steve Bell, vice president of research and pre-clinical development for BioSante, will present the new findings in a case study report on the ongoing research and development of a next generation needle-free anthrax (rPA) vaccine using BioVant(TM), the company's patented calcium phosphate (CaP) nanoparticulate technology.
Source:
genengnews.com
Related News Press |
Nanomedicine
High-tech 'paint' could spare patients repeated surgeries March 8th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||